alpha-adrenergic receptor — Drug Target
All drugs that target alpha-adrenergic receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
alpha-adrenergic receptor antagonist
Phase 3 pipeline (1)
- Phentolamine Mesylate (NV-101) · Novalar Pharmaceuticals, Inc. · alpha-adrenergic receptor antagonist · Cardiovascular
Phentolamine mesylate is an alpha-adrenergic receptor antagonist that works by blocking the action of norepinephrine, a neurotransmitter that can cause blood vessels to constrict.